002422 Sichuan Kelun Pharmaceutical
- 32.66
- +1.61+5.19%
Sichuan Kelun Pharmaceutical News
Colon Pharmaceuticals: An indicative announcement on the upcoming expiration of the 2021 Employee Stock Ownership Plan
Colon Pharmaceutical: Announcement on the completion of non-transactional transfers of shares eligible for unlocking during the second unlocking period of the 2022 Employee Stock Ownership Plan
Colon Pharmaceuticals: 2024 Mid-Term Dividend Implementation Notice
Colon Pharmaceuticals: An indicative announcement on the expiration of the second lockdown period of the 2022 employee stock ownership plan
Colon Pharmaceutical: Announcement on the pledge and cancellation of the pledge of some of the shares of the controlling shareholder of the company
Colon Pharmaceuticals: Announcement on the Company\'s 2024 Mid-Term Profit Distribution Plan
Sichuan Kelun Pharmaceutical: Announcement on Pledging and Lifting the Pledge of Partial Equity of the Company's Controlling Shareholders.
Sichuan Kelun Pharmaceutical: Announcement on Pledging and Lifting the Pledge of Partial Equity of the Company's Controlling Shareholders.
Sichuan Kelun Pharmaceutical: Announcement on Pledging and Lifting the Pledge of Partial Equity of the Company's Controlling Shareholders.
Sichuan Kelun Pharmaceutical: Regarding the advisory notice on the first release of the 2021 Restricted Stock Incentive Plan and the second unlocking period for restricted shares to be listed and traded.
Sichuan Kelun Pharmaceutical: Reminder announcement on the end of the second lockdown period of the 2021 Employee Stock Ownership Plan
Sichuan Kelun Pharmaceutical: Announcement on partial share pledges and cancellation of pledges by the controlling shareholder of the company
Sichuan Kelun Pharmaceutical: 2023 dividend payment implementation announcement
Sichuan Kelun Pharmaceutical: Announcement on the repurchase and cancellation of some restricted stocks in the 2021 Restricted Stock Incentive Plan
Sichuan Kelun Pharmaceutical: Announcement on the achievements of the 2021 Restricted Stock Incentive Plan to lift the conditions for lifting the restrictions during the second period of the restricted sales period
Sichuan Kelun Pharmaceutical: Independent Financial Advisory Report of Shanghai Xingong Yihe Enterprise Management Consulting Co., Ltd. on matters relating to the lifting of sales restrictions during the second period of the 2021 Restricted Stock Incentive Plan of Sichuan Kelun Pharmaceutical Co., Ltd.
Sichuan Kelun Pharmaceutical: Legal opinion on matters relating to the fulfillment of the conditions for lifting sales restrictions and the repurchase and cancellation of some restricted stocks in the 2021 Restricted Stock Incentive Plan of Sichuan Colon Pharmaceutical Co., Ltd.
Colon Pharmaceutical: Announcement on the pledge and cancellation of the pledge of some of the shares of the controlling shareholder of the company
Colon Pharmaceuticals: Announcement on partial share pledges by shareholders holding 5% or more of the company\'s shares
Colon Pharmaceutical: Announcement of Sichuan Colon Pharmaceutical Co., Ltd. on the completion of partial restricted stock repurchase and cancellation of the 2021 restricted stock incentive plan and no adjustment of the conversion price
Analysis
Price Target
No Data
No Data